Preclinical News and Research

RSS
NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix raises $30.2 million through Series B financing

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

Shire announces third quarter 2009 financial results

Shire announces third quarter 2009 financial results

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

Geron plans to advance clinical program for spinal cord injury

Geron plans to advance clinical program for spinal cord injury

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Data from multiple clinical and preclinical studies evaluating Hematide announced

Data from multiple clinical and preclinical studies evaluating Hematide announced

Helper T cell's effect raises possibility of cellular therapy and vaccine development

Helper T cell's effect raises possibility of cellular therapy and vaccine development

Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

New state-of-the-art biotechnology center opened on the West Coast

New state-of-the-art biotechnology center opened on the West Coast

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Third-quarter 2009 financial results of Antigenics announced

Third-quarter 2009 financial results of Antigenics announced

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

Third-quarter fiscal 2009 results announced by Curis

Third-quarter fiscal 2009 results announced by Curis

Report on marketing the bio-pharmaceutical products released

Report on marketing the bio-pharmaceutical products released

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.